menu
    • menu

    Company profile for LENZ Therapeutics

    NEW Drugs in Dev: 3
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    AbbVie Contract Manufacturing partners globally to develop, scale, and manufacture pharmaceutical products successfully.

    Virtual Booth

    Contact Supplier

    Topscience Biotech is a one-stop supplier of sodium hyaluronate//drug manufacturing license, CEP, GMP, DMF, and Form 41 certifications.

    Virtual Booth

    Contact Supplier

    Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    LENZ Therapeutics is a late-stage clinical company developing innovative ophthalmic pharmaceutical products. LENZ Therapeutics is a late-stage clinical company developing innovative ophthalmic pharmaceutical products that improve vision. Our lead program is an aceclidine based eye drop designed to restore the loss of near vision associated with presbyopia. Presbyopia impacts almost two billion people globally and more than 1...
    LENZ Therapeutics is a late-stage clinical company developing innovative ophthalmic pharmaceutical products. LENZ Therapeutics is a late-stage clinical company developing innovative ophthalmic pharmaceutical products that improve vision. Our lead program is an aceclidine based eye drop designed to restore the loss of near vision associated with presbyopia. Presbyopia impacts almost two billion people globally and more than 120 million people in the US. LENZ Therapeutics is headquartered in San Diego, California, and is backed by multiple blue-chip venture capital investors.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    LENZ TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    San Diego, CA
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://lenz-tx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/lenztx/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    LENZ Therapeutics: Everest Acquires VIZZ Rights for China
    LENZ Therapeutics: Everest Acquires VIZZ Rights for China

    07 Jun 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/06/07/3307756/0/en/lenz-therapeutics-announces-everest-medicines-acquired-rights-to-develop-and-commercialize-vizz-lnz100-in-greater-china.html

    GLOBENEWSWIRE
    07 Jun 2026
    Share Share
    LENZ Therapeutics to Join Upcoming Investor Conferences
    LENZ Therapeutics to Join Upcoming Investor Conferences

    26 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/26/3301004/0/en/lenz-therapeutics-to-participate-in-upcoming-investor-conferences.html

    GLOBENEWSWIRE
    26 May 2026
    Share Share
    LENZ Therapeutics Reports Q1 2026 Results, Highlights
    LENZ Therapeutics Reports Q1 2026 Results, Highlights

    11 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/11/3292325/0/en/lenz-therapeutics-reports-first-quarter-2026-financial-results-and-recent-corporate-highlights.html

    GLOBENEWSWIRE
    11 May 2026
    Share Share
    LENZ Therapeutics to Report Q1 2026 Results on May 11
    LENZ Therapeutics to Report Q1 2026 Results on May 11

    04 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/04/3286635/0/en/lenz-therapeutics-to-report-first-quarter-2026-financial-results-and-recent-corporate-highlights-on-may-11-2026-and-attend-upcoming-investor-conference.html

    GLOBENEWSWIRE
    04 May 2026
    Share Share
    LENZ Files UK Marketing Application for VIZZ Presbyopia Drug
    LENZ Files UK Marketing Application for VIZZ Presbyopia Drug

    20 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/20/3276928/0/en/lenz-therapeutics-announces-submission-of-marketing-authorization-application-to-the-medicines-and-healthcare-products-regulatory-agency-for-vizz-for-the-treatment-of-presbyopia-in.html

    GLOBENEWSWIRE
    20 Apr 2026
    Share Share
    LENZ Therapeutics Reveals 2025 Financials And Corporate Updates
    LENZ Therapeutics Reveals 2025 Financials And Corporate Updates

    24 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/24/3261171/0/en/LENZ-Therapeutics-Reports-Fourth-Quarter-and-Full-Year-2025-Financial-Results-and-Recent-Corporate-Highlights.html

    GLOBENEWSWIRE
    24 Mar 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search